Prasco announces executive changes

CINCINNATI — Generic drug maker Prasco Labs has named Christopher Arington its vice chairman and CEO.

In addition to Arington's promotion, David Vucurevich was promoted to president and COO, David Furniss was named CFO and Chris Gilmore was appointed VP strategic business ventures.

The moves were announced by Prasco chairman E. Thomas Arington.

Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

Login or Register to post a comment.